Kineta Inc (KA)
0.61
-0.03
(-4.66%)
USD |
NASDAQ |
Apr 26, 16:00
0.61
0.00 (0.00%)
After-Hours: 20:00
Kineta Enterprise Value: 1.843M for April 26, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 26, 2024 | 1.843M |
April 25, 2024 | 2.170M |
April 24, 2024 | 1.953M |
April 23, 2024 | 2.499M |
April 22, 2024 | 2.116M |
April 19, 2024 | 0.9332M |
April 18, 2024 | 0.4849M |
April 17, 2024 | 0.3084M |
April 16, 2024 | 0.4147M |
April 15, 2024 | -1.117M |
April 12, 2024 | -0.8646M |
April 11, 2024 | -0.0205M |
April 10, 2024 | -0.7879M |
April 09, 2024 | -0.1301M |
April 08, 2024 | 1.076M |
April 05, 2024 | 1.294M |
April 04, 2024 | 1.268M |
April 03, 2024 | 1.400M |
April 02, 2024 | 0.566M |
April 01, 2024 | 0.7085M |
March 28, 2024 | 0.9146M |
March 27, 2024 | 0.8708M |
March 26, 2024 | 1.208M |
March 25, 2024 | 1.248M |
March 22, 2024 | 2.280M |
Date | Value |
---|---|
March 21, 2024 | 1.647M |
March 20, 2024 | 1.350M |
March 19, 2024 | 1.041M |
March 18, 2024 | 1.260M |
March 15, 2024 | 0.8224M |
March 14, 2024 | 1.505M |
March 13, 2024 | 1.553M |
March 12, 2024 | 1.664M |
March 11, 2024 | 2.330M |
March 08, 2024 | 2.382M |
March 07, 2024 | 3.141M |
March 06, 2024 | 3.268M |
March 05, 2024 | 3.682M |
March 04, 2024 | 5.657M |
March 01, 2024 | 4.420M |
February 29, 2024 | 3.682M |
February 28, 2024 | 18.65M |
February 27, 2024 | 18.65M |
February 26, 2024 | 19.28M |
February 23, 2024 | 21.36M |
February 22, 2024 | 22.29M |
February 21, 2024 | 22.19M |
February 20, 2024 | 22.19M |
February 16, 2024 | 24.58M |
February 15, 2024 | 22.19M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-1.117M
Minimum
Apr 15 2024
76.32M
Maximum
Dec 30 2022
24.37M
Average
22.29M
Median
Jan 23 2024
Enterprise Value Benchmarks
Ironwood Pharmaceuticals Inc | 1.830B |
Ampio Pharmaceuticals Inc | -3.724M |
NovaBay Pharmaceuticals Inc | 2.329M |
Palatin Technologies Inc | 19.88M |
iBio Inc | 16.00M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -2.654M |
Total Expenses (Quarterly) | 4.271M |
EPS Diluted (Quarterly) | -0.19 |
Earnings Yield | -226.2% |
Normalized Earnings Yield | -1866.28 |